Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Human Gene Therapy|September 14, 2012
Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responsesKoen Oosterhuis, Esil Aleyd, Kim Vrijland, et al.Current Clinical Pharmacology|April 22, 2010
DNA vaccination in oncology: current status, opportunities and perspectivesJoost H van den Berg, Koen Oosterhuis, Jos H Beijnen, et al.International Orthopaedics|August 1, 2012
Complications after plate fixation and elastic stable intramedullary nailing of dislocated midshaft clavicle fractures: a retrospective comparisonFrans-Jasper Wijdicks, Marijn Houwert, Marcel Dijkgraaf, et al.International Journal of Cancer|January 6, 2011
Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7Koen Oosterhuis, Peter Ohlschläger, Joost H van den Berg, et al.Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Intradermal vaccination by DNA tattooingJoost H van den Berg, Koen Oosterhuis, Ton N M Schumacher, et al.Oncoimmunology|October 25, 2019
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor controlElena Tondini, Tsolere Arakelian, Koen Oosterhuis, et al.Arthritis Research & Therapy|June 29, 2006
Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB geneKen-ichi Ogawara, Joanna M Kułdo, Koen Oosterhuis, et al.American Journal of Physiology. Cell Physiology|June 24, 2005
Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitroJoanna M Kuldo, Johanna Westra, Sigridur A Asgeirsdóttir, et al.Vaccine|February 18, 2022
Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccinationTsolere Arakelian, Koen Oosterhuis, Elena Tondini, et al.Vaccine|June 20, 2018
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responsesMarija Vujadinovic, Selina Khan, Koen Oosterhuis, et al.Pageof 2